Budget Amount *help |
¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2014: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2013: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2012: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
|
Outline of Final Research Achievements |
The therapeutic effects of ETS-GS, a novel vitamin E derivative with antioxidative and anti-inflammatory abilities, were examined in a rat model of radiation enterocolitis. The radiation enterocolitis model was created by irradiation of rats with a single dose of 10 Gy. ETS-GS was administered subcutaneously (10 mg/kg/day) for five consecutive days from two days prior to irradiation. The ileal mucous membrane disorder of the ETS-GS administrated group was controlled in comparison with radiation exposure that received no ETS-GS group. In the ETS-GS administrated group, various inflammatory and oxidative stress markers were significantly lower than radiation exposure alone group. In this study, ETS-GS with antioxidant activity has a therapeutic effect on the symptoms of radiation enterocolitis in a rat model. Subsequently, the effectiveness of the ETS-GS for radiation dermatitis model is planned to study.
|